MARKET

ARTH

ARTH

Arch Therapeutics Inc
OTCPK
0.248
NaN%
Closed 09:30 03/24 EDT
OPEN
--
PREV CLOSE
0.248
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.140
52 WEEK LOW
0.170
MARKET CAP
1.10M
P/E (TTM)
-0.0670
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARTH last week (0317-0321)?
Weekly Report · 1d ago
Weekly Report: what happened at ARTH last week (0310-0314)?
Weekly Report · 03/17 09:32
Weekly Report: what happened at ARTH last week (0303-0307)?
Weekly Report · 03/10 09:33
Weekly Report: what happened at ARTH last week (0224-0228)?
Weekly Report · 03/03 09:33
Weekly Report: what happened at ARTH last week (0217-0221)?
Weekly Report · 02/24 09:33
Weekly Report: what happened at ARTH last week (0210-0214)?
Weekly Report · 02/17 09:32
Weekly Report: what happened at ARTH last week (0203-0207)?
Weekly Report · 02/10 09:31
Arch Therapeutics Announces Leadership Reshuffle in 2025
TipRanks · 02/07 21:34
More
About ARTH
Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.

Webull offers Arch Therapeutics Inc stock information, including OTCPK: ARTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARTH stock methods without spending real money on the virtual paper trading platform.